tradingkey.logo
tradingkey.logo
Buscar

Bio Rad Laboratories Inc

BIO
Añadir a la lista de seguimiento
243.510USD
+1.800+0.74%
Cierre 05/13, 16:00ETCotizaciones retrasadas 15 min
6.57BCap. mercado
40.38P/E TTM

Bio Rad Laboratories Inc

243.510
+1.800+0.74%

Más Datos de Bio Rad Laboratories Inc Compañía

Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. It operates through two segments: Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes, food testing regimes, and science education. Its Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.

Información de Bio Rad Laboratories Inc

Símbolo de cotizaciónBIO
Nombre de la empresaBio Rad Laboratories Inc
Fecha de salida a bolsaMar 17, 1980
Director ejecutivoSchwartz (Norman D)
Número de empleados7700
Tipo de seguridadOrdinary Share
Fin del año fiscalMar 17
Dirección1000 Alfred Nobel Dr
CiudadHERCULES
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited States of America
Código postal94547
Teléfono15107247000
Sitio Webhttps://www.bio-rad.com/
Símbolo de cotizaciónBIO
Fecha de salida a bolsaMar 17, 1980
Director ejecutivoSchwartz (Norman D)

Ejecutivos de Bio Rad Laboratories Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Norman D. Schwartz
Mr. Norman D. Schwartz
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
1.38M
-1.00%
Ms. Colleen Corey
Ms. Colleen Corey
Executive Vice President, Global Human Resources
Executive Vice President, Global Human Resources
19.55K
+5.48%
Mr. Sedat Evran
Mr. Sedat Evran
Executive Vice President - Global Supply Chain
Executive Vice President - Global Supply Chain
2.02K
+35.01%
Mr. Gregory K. (Greg) Hinckley, CPA
Mr. Gregory K. (Greg) Hinckley, CPA
Lead Independent Director
Lead Independent Director
1.22K
+33.50%
Ms. Eva Anette Engelhardt
Ms. Eva Anette Engelhardt
Executive Vice President, President of Clinical Diagnostics Group
Executive Vice President, President of Clinical Diagnostics Group
896.00
+82.48%
Ms. Courtney C Enloe
Ms. Courtney C Enloe
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
721.00
+15.12%
Mr. Jeffrey L. (Jeff) Edwards
Mr. Jeffrey L. (Jeff) Edwards
Independent Director
Independent Director
715.00
+56.92%
Mr. Arnold A. Pinkston
Mr. Arnold A. Pinkston
Independent Director
Independent Director
715.00
+56.92%
Ms. Melinda Litherland
Ms. Melinda Litherland
Independent Director
Independent Director
308.00
--
Rajat Mehta
Rajat Mehta
Executive Vice President - Global Commercial Operations
Executive Vice President - Global Commercial Operations
58.00
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Norman D. Schwartz
Mr. Norman D. Schwartz
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
1.38M
-1.00%
Ms. Colleen Corey
Ms. Colleen Corey
Executive Vice President, Global Human Resources
Executive Vice President, Global Human Resources
19.55K
+5.48%
Mr. Sedat Evran
Mr. Sedat Evran
Executive Vice President - Global Supply Chain
Executive Vice President - Global Supply Chain
2.02K
+35.01%
Mr. Gregory K. (Greg) Hinckley, CPA
Mr. Gregory K. (Greg) Hinckley, CPA
Lead Independent Director
Lead Independent Director
1.22K
+33.50%
Ms. Eva Anette Engelhardt
Ms. Eva Anette Engelhardt
Executive Vice President, President of Clinical Diagnostics Group
Executive Vice President, President of Clinical Diagnostics Group
896.00
+82.48%
Ms. Courtney C Enloe
Ms. Courtney C Enloe
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
721.00
+15.12%

Desglose de ingresos

Divisa: USDActualizado: lun., 6 de abr
Divisa: USDActualizado: lun., 6 de abr
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
La empresa aún no ha revelado los datos relevantes.
Por regiónUSD
Nombre
Ganancia
Proporción
United States
1.02B
39.59%
Europe
881.80M
34.14%
APAC
513.30M
19.87%
Other
165.40M
6.40%
Por negocio
Por región
La empresa aún no ha revelado los datos relevantes.

Estadísticas de accionistas

Actualizado: dom., 10 de may
Actualizado: dom., 10 de may
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
First Eagle Investment Management, L.L.C.
11.85%
Alice N. Schwartz Revocable Trust
8.21%
BlackRock Institutional Trust Company, N.A.
6.73%
Schwartz (Norman D)
6.36%
Dimensional Fund Advisors, L.P.
5.02%
Otro
61.84%
Accionistas
Accionistas
Proporción
First Eagle Investment Management, L.L.C.
11.85%
Alice N. Schwartz Revocable Trust
8.21%
BlackRock Institutional Trust Company, N.A.
6.73%
Schwartz (Norman D)
6.36%
Dimensional Fund Advisors, L.P.
5.02%
Otro
61.84%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor/Hedge Fund
44.15%
Investment Advisor
40.11%
Individual Investor
8.27%
Corporation
8.21%
Hedge Fund
4.12%
Research Firm
2.06%
Pension Fund
1.08%
Bank and Trust
0.89%
Sovereign Wealth Fund
0.53%

Participación institucional

Actualizado: dom., 5 de abr
Actualizado: dom., 5 de abr
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2026Q1
1041
18.42M
84.86%
-4.19M
2025Q4
1040
20.58M
101.60%
-3.97K
2025Q3
1095
20.58M
103.17%
+603.60K
2025Q2
1114
19.81M
108.02%
-855.27K
2025Q1
1146
19.96M
99.31%
-2.83M
2024Q4
1140
19.39M
101.48%
-657.49K
2024Q3
1121
20.03M
101.42%
-386.71K
2024Q2
1139
20.32M
91.46%
+1.29M
2024Q1
1154
19.07M
91.02%
-2.25M
2023Q4
1187
19.09M
89.28%
-259.69K
Ver más

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
First Eagle Investment Management, L.L.C.
2.57M
11.72%
+50.15K
+1.99%
Dec 31, 2025
Alice N. Schwartz Revocable Trust
1.78M
8.13%
--
--
Feb 23, 2026
BlackRock Institutional Trust Company, N.A.
1.46M
6.66%
-23.75K
-1.60%
Dec 31, 2025
Schwartz (Norman D)
1.38M
6.3%
-13.77K
-0.99%
Feb 23, 2026
Dimensional Fund Advisors, L.P.
1.08M
4.91%
+14.13K
+1.33%
Dec 31, 2025
Ariel Investments, LLC
764.67K
3.49%
-44.81K
-5.54%
Dec 31, 2025
EARNEST Partners, LLC
603.59K
2.75%
-5.69K
-0.93%
Dec 31, 2025
State Street Investment Management (US)
559.60K
2.55%
-11.99K
-2.10%
Dec 31, 2025
Ver más

ETFs relacionados

Actualizado: sáb., 6 de dic
Actualizado: sáb., 6 de dic
Nombre
Proporción
Parnassus Value Select ETF
3.94%
First Trust Indxx Medical Devices ETF
2.15%
ROBO Global Healthcare Technology & Innovation ETF
1.61%
Schwab Ariel Opportunities ETF
1.6%
First Trust Health Care Alphadex Fund
1.49%
FPA Global Equity ETF
1.38%
First Eagle Global Equity ETF
1.21%
iShares Health Innovation Active ETF
1.17%
Pacer US Export Leaders ETF
1.03%
Harbor Health Care ETF
0.82%
Ver más
Parnassus Value Select ETF
Proporción3.94%
First Trust Indxx Medical Devices ETF
Proporción2.15%
ROBO Global Healthcare Technology & Innovation ETF
Proporción1.61%
Schwab Ariel Opportunities ETF
Proporción1.6%
First Trust Health Care Alphadex Fund
Proporción1.49%
FPA Global Equity ETF
Proporción1.38%
First Eagle Global Equity ETF
Proporción1.21%
iShares Health Innovation Active ETF
Proporción1.17%
Pacer US Export Leaders ETF
Proporción1.03%
Harbor Health Care ETF
Proporción0.82%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos

División de acciones

Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
KeyAI